NCT05267873View on ClinicalTrials.gov

Combining Data Sources to Identify Effect Moderation for Personalized Mental Health

CompletedOBSERVATIONAL

Enrollment

9,586

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 31, 2021

Study Completion Date

December 1, 2024

Conditions

Depressive Disorder, Major

Interventions

DRUG

Duloxetine, Vortioxetine

Medications for major depressive disorder

Trial Locations (1)

21205

Johns Hopkins Bloomberg School of Public Health, Baltimore

Sponsors

Collaborators (1)

Duke University

All Listed Sponsors

collaborator

Duke University

OTHER

collaborator

Patient-Centered Outcomes Research Institute

OTHER

collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Johns Hopkins Bloomberg School of Public Health

OTHER

NCT05267873 - Combining Data Sources to Identify Effect Moderation for Personalized Mental Health | Biotech Hunter | Biotech Hunter